Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Laura Z. Vanags"'
Autor:
Laura Z. Vanags, PhD, Joanne T.M. Tan, PhD, Keyvan K. Galougahi, MD, PhD, Andreas Schaefer, MD, Steven G. Wise, PhD, Andrew Murphy, PhD, Ziad A. Ali, MD, PhD, Christina A. Bursill, PhD
Publikováno v:
JACC: Basic to Translational Science, Vol 3, Iss 2, Pp 200-209 (2018)
Summary: Even the most advanced drug-eluting stents evoke unresolved issues, including chronic inflammation, late thrombosis, and neoatherosclerosis. This highlights the need for novel strategies that improve stent biocompatibility. Our studies show
Externí odkaz:
https://doaj.org/article/d8d4a7812f1546ab8a5dc2f65548598b
Autor:
Jamie Morton, MBBS, PhD, Shisan Bao, MD, PhD, Laura Z. Vanags, BSc, PhD, Tania Tsatralis, BSc, Anisyah Ridiandries, BSc, PhD, Chung-Wah Siu, MBBS, MD, Kwong-Man Ng, BSc, PhD, Joanne T.M. Tan, BSc, PhD, David S. Celermajer, MBBS, PhD, Martin K.C. Ng, MBBS, PhD, Christina A. Bursill, BSc, PhD
Publikováno v:
JACC: Basic to Translational Science, Vol 3, Iss 2, Pp 187-199 (2018)
Summary: Preclinical studies have shown benefit of apolipoprotein A-I (apoA-I)/high-density lipoprotein (HDL) raising in atherosclerosis; however, this has not yet translated into a successful clinical therapy. Our studies demonstrate that apoA-I rai
Externí odkaz:
https://doaj.org/article/191bf6b8123e4c32927bf2bc5abbd323
Autor:
Nathan K. P. Wong, Helena Cheung, Emma L. Solly, Laura Z. Vanags, William Ritchie, Stephen J. Nicholls, Martin K. C. Ng, Christina A. Bursill, Joanne T. M. Tan
Publikováno v:
International Journal of Molecular Sciences, Vol 19, Iss 7, p 1903 (2018)
Angiogenesis, the process of forming new blood vessels, is crucial in the physiological response to ischemia, though it can be detrimental as part of inflammation and tumorigenesis. We have previously shown that high-density lipoproteins (HDL) modula
Externí odkaz:
https://doaj.org/article/a51a36687992442dba358fe0bbbf6314
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 38:1691-1701
Revascularization because of coronary artery disease is commonly achieved by percutaneous coronary intervention with stent deployment. Refinement in interventional techniques, major improvements in stent design (particularly drug-eluting stents), and
Autor:
Andrew J. Murphy, Andreas Schaefer, Ziad A. Ali, Keyvan Karimi Galougahi, Laura Z. Vanags, Christina A. Bursill, Steven G. Wise, Joanne T.M. Tan
Publikováno v:
JACC: Basic to Translational Science
JACC: Basic to Translational Science, Vol 3, Iss 2, Pp 200-209 (2018)
JACC: Basic to Translational Science, Vol 3, Iss 2, Pp 200-209 (2018)
Visual Abstract
Highlights • This study shows that apoA-I may be an alternative strategy to improve the biocompatibility of stents. • Systemic infusions of apoA-I reduce in-stent neointimal hyperplasia in a murine model of stenting. • The
Highlights • This study shows that apoA-I may be an alternative strategy to improve the biocompatibility of stents. • Systemic infusions of apoA-I reduce in-stent neointimal hyperplasia in a murine model of stenting. • The
Autor:
Kwong Man Ng, Jamie Morton, Joanne T.M. Tan, Laura Z. Vanags, Anisyah Ridiandries, David S. Celermajer, Tania Tsatralis, Shisan Bao, Chung-Wah Siu, Martin K.C. Ng, Christina A. Bursill
Publikováno v:
JACC: Basic to Translational Science, Vol 3, Iss 2, Pp 187-199 (2018)
JACC: Basic to Translational Science
JACC: Basic to Translational Science
Visual Abstract
Highlights • The atheroprotective effects of apoA-I are dependent on the plaque stage from which apoA-I is infused. • The atheroprotective effects of apoA-I infusions are also impaired in older mice with a greater disease mil
Highlights • The atheroprotective effects of apoA-I are dependent on the plaque stage from which apoA-I is infused. • The atheroprotective effects of apoA-I infusions are also impaired in older mice with a greater disease mil
Autor:
Ziad A. Ali, Marcela M.M. Bilek, Laura Z. Vanags, Joanne T.M. Tan, Praveesuda S. Michael, Steven G. Wise, Christina A. Bursill, Miguel Santos
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine. 13:2141-2150
We utilized a plasma activated coating (PAC) to covalently bind the active component of high density lipoproteins (HDL), apolipoprotein (apo) A-I, to stainless steel (SS) surfaces. ApoA-I suppresses restenosis and thrombosis and may therefore improve
Autor:
Laura Lecce, Yuen Ting Lam, Zoe E. Clayton, Stacy Robertson, Tania Tsatralis, David S. Celermajer, Sui Ching G. Yuen, Joanne T.M. Tan, Louise L. Dunn, Martin K.C. Ng, Hamish C. G. Prosser, Christina A. Bursill, Anisyah Ridiandries, Laura Z. Vanags
Publikováno v:
Diabetes. 65:3091-3103
Disordered neovascularization and impaired wound healing are important contributors to diabetic vascular complications. We recently showed that high-density lipoproteins (HDLs) enhance ischemia-mediated neovascularization, and mounting evidence sugge
Autor:
Christina A. Bursill, Benjamin M. Weimann, Zoe E. Clayton, Anisyah Ridiandries, Stacy Robertson, Joanne T.M. Tan, Tania Tsatralis, Laura Z. Vanags, Martin K.C. Ng, Emma L. Solly, Jennifer Q. J. Zhang, Samuel T. Hourigan, Edward R. Tepper, Victoria A. Nankivell, Rodney Henriquez, Stephen J. Nicholls
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-14 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-14 (2018)
Diabetic vascular complications are associated with impaired ischaemia-driven angiogenesis. We recently found that reconstituted high-density lipoproteins (rHDL) rescue diabetes-impaired angiogenesis. microRNAs (miRNAs) regulate angiogenesis and are
Publikováno v:
Arteriosclerosis, thrombosis, and vascular biology. 38(8)
Revascularization because of coronary artery disease is commonly achieved by percutaneous coronary intervention with stent deployment. Refinement in interventional techniques, major improvements in stent design (particularly drug-eluting stents), and